| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| Alcohol / Addiction / Illegal Drugs News | |
| Study Identifies 'respectable Addicts' Experiencing Range Of Problems With Over-the-counter Medicines A report of a study investigating over the counter medicine (OTC) abuse published by the Pharmacy Practice Research Trust provides evidence that there is a group of individuals experiencing a range of problems often with codeine-based medicines purchased from pharmacies, and for whom help and support varied. | 06 Sept 2011 |
| Arthritis / Rheumatology News | |
| Chondroitin Sulphate Effective Treatment For Patients With Osteoarthritis Chondroitin sulfate has been revealed in a new investigation to considerably reduce pain, improve hand function, enhance grip strength and relieve morning stiffness for individuals with osteoarthritis (OA) of the hand, in comparison with patients in the placebo group. | 06 Sept 2011 |
| Asbestos / Mesothelioma News | |
| Asbestos Warning - Mesothelioma Cases Reported In Home Renovators According to an article published in the Medical Journal of Australia a new study revealed that home renovations in Australia are causing an alarming number of asbestos-related disease in men and women. | 06 Sept 2011 |
| Biology / Biochemistry News | |
| Key Protein Reveals Secret Of Stem Cell Pluripotency A protein that helps maintain mouse stem cell pluripotency has been identified by researchers at the RIKEN Omics Science Center. The finding, published in the August issue of Stem Cells (first published online July 26, 2011), points the way to advances in regenerative medicine and more effective culturing techniques for human pluripotent stem cells. | 06 Sept 2011 |
| New Drugs Hope For Dangerous Yeast Infections Researchers are a step closer towards creating a new class of medicines and vaccines to combat drug-resistant and deadly strains of fungal infections, following a new study published today in Proceedings of the National Academy of Sciences. | 06 Sept 2011 |
| Complex System Transports Essential Cargoes Such As Proteins And Membrane Vesicles Every cell in the human body contains a complex system to transport essential cargoes such as proteins and membrane vesicles, from point A to point B. These tiny molecular motor proteins move at blistering speeds on miniature railways carrying components of the cell to their proper destinations. | 06 Sept 2011 |
| Profiler At The Cellular Level Researchers led by ETH professor Yaakov Benenson and MIT professor Ron Weiss have successfully incorporated a diagnostic biological "computer" network in human cells. This network recognizes certain cancer cells using logic combinations of five cancer-specific molecular factors, triggering cancer cells destruction. | 06 Sept 2011 |
| Orchestrator Of Waste Removal Rescues Cells That Can't Manage Their Trash Just as we must take out the trash to keep our homes clean and safe, it is essential that our cells have mechanisms for dealing with wastes and worn-out proteins. When these processes are not working properly, unwanted debris builds up in the cell and creates a toxic environment. | 06 Sept 2011 |
| Blood / Hematology News | |
| Blood Supply Threatened By Tickborne Parasite Babesia, Screening Of Blood Donors Required, Says CDC US blood supplies are becoming increasingly infected with Babesia, a tickborne parasite of red blood cells. The infection is transmitted through blood transfusions. Since 1979, when transfusion-associated babesiosis was first reported, the number of reported cases has been progressively increasing, the CDC (Centers for Disease Control and Prevention) announced in Annals of Internal Medicine after carrying out a collaborative study of the last thirty years. | 06 Sept 2011 |
| BBC's Holby City Criticized By Trauma Experts For 'Peddling Dangerous Drugs' Trauma experts have criticized the BBC over a recent episode of Holby City that effectively advertised and promoted a drug that has no proven record of saving lives.According to Dr Ian Roberts, Head of the World Health Organisation Collaborating Centre on Injury Control at the London School of Hygiene & Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously misrepresents the scientific evidence. | 06 Sept 2011 |
| Breast Cancer News | |
| Walnuts Reduce Breast Cancer Risk By Half In Animal Studies Mice fed a diet that included daily walnuts had half the risk of developing breast cancer compared to those on a typical diet, researchers from Marshal University School of Medicine reported in the journal Nutrition and Cancer. | 06 Sept 2011 |
| If Environmental Conditions Of Tumors Are Changed, The Process Reverses Like snakes, tumour cells shed their skin. Cancer is not a static disease but during its development the disease accumulates changes to evade natural defences adapting to new environmental circumstances, protecting against chemotherapy and radiotherapy and invading neighbouring organs, eventually causing metastasis. | 06 Sept 2011 |
| Cancer / Oncology News | |
| New Strategy For Treating Cancer Using a strategy based on treating cancer cells that carry a specific genetic signature hyper-expression of the protein Myc with therapy that affects the stability of the cell's DNA, more effective results can be achieved. | 06 Sept 2011 |
| New Cancer Killer - A Harmless Soil-Dwelling Bacteria A bacterial strain that specifically targets tumours could soon be used as a vehicle to deliver drugs in frontline cancer therapy. The strain is expected to be tested in cancer patients in 2013 says a scientist at the Society for General Microbiology's Autumn Conference at the University of York. | 06 Sept 2011 |
| If Environmental Conditions Of Tumors Are Changed, The Process Reverses Like snakes, tumour cells shed their skin. Cancer is not a static disease but during its development the disease accumulates changes to evade natural defences adapting to new environmental circumstances, protecting against chemotherapy and radiotherapy and invading neighbouring organs, eventually causing metastasis. | 06 Sept 2011 |
| Tricking The Body To Heal Itself With Low-Dose Naltrexone (LDN) Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on cell proliferation. | 06 Sept 2011 |
| Profiler At The Cellular Level Researchers led by ETH professor Yaakov Benenson and MIT professor Ron Weiss have successfully incorporated a diagnostic biological "computer" network in human cells. This network recognizes certain cancer cells using logic combinations of five cancer-specific molecular factors, triggering cancer cells destruction. | 06 Sept 2011 |
| Cardiovascular / Cardiology News | |
| Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or 'Off-The-Shelf' Stem Cell Treatment For Heart Attacks Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. | 06 Sept 2011 |
| AHA Gives Loyola $195,000, Bringing Lifetime Total To $10.1 Million The American Heart Association has awarded the Cardiovascular Institute of Loyola University Chicago Stritch School of Medicine $194,772 for cardiac research in 2011, bringing the lifetime total awarded to Loyola to $10. | 06 Sept 2011 |
| Cervical Cancer / HPV Vaccine News | |
| NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. | 06 Sept 2011 |
| Clinical Trials / Drug Trials News | |
| Chugai Initiates Clinical Trials For Multiple In-Licensed Compounds Utilizing The Personalized Healthcare Strategy Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President: Osamu Nagayama (hereafter, "Chugai")] announced that it has entered into license agreements with F. Hoffmann-La Roche, Ltd [Head Office: Basel, Switzerland / CEO: Severin Schwan (hereafter, "Roche")] covering humanized anti-Met antibody MetMAb, for non-small cell lung cancer (NSCLC) and humanized anti-interleukin(IL)-13 antibody lebrikizumab for bronchial asthma which are both currently developed by Roche utilizing the Personalized Healthcare (PHC) approach and have also entered phase I clinical studies in the Japanese population. | 06 Sept 2011 |
| Colorectal Cancer News | |
| Human Intestinal Stem Cell 'Breakthrough' For Regenerative Medicine Announced By Scientists Human colon stem cells have been identified and grown in a lab-plate for the first time. This achievement, made by researchers of the Colorectal Cancer Lab at the Institute for Research in Biomedicine (IRB Barcelona) and published in /i>Nature Medicine, is a crucial advance towards regenerative medicine. | 06 Sept 2011 |
| If Environmental Conditions Of Tumors Are Changed, The Process Reverses Like snakes, tumour cells shed their skin. Cancer is not a static disease but during its development the disease accumulates changes to evade natural defences adapting to new environmental circumstances, protecting against chemotherapy and radiotherapy and invading neighbouring organs, eventually causing metastasis. | 06 Sept 2011 |
| Cystic Fibrosis News | |
| An 'Unconventional' Path To Correcting Cystic Fibrosis Researchers have identified an unconventional path that may correct the defect underlying cystic fibrosis, according to a report in the September 2nd issue of the journal Cell, a Cell Press publication. | 06 Sept 2011 |
| Depression News | |
| Valdoxan More Effective On Patients With Major Depressive Disorder Than Common Antidepressants The European College of Neuropsychopharmacology Congress (ECNP) highlighted new data regarding the high efficiency of Valdoxan® (agomelatine) in comparison with other commonly prescribed antidepressants showing that the drug is stronger and therefore significantly more beneficial for depressed patients with severe anxiety symptoms. | 06 Sept 2011 |
| Diabetes News | |
| No Cure For Diabetes, But Lifestyle Changes Can Be The Difference Not to state the obvious, but diabetes is a clear threat to the human species and needs to be addressed. It is also important to remind ourselves of the things we can do in life to avoid the epidemic. | 06 Sept 2011 |
| Diabetes Risk 80% Lower For Those With Multiple Good Lifestyle Factors, Compared To Those With Worst Individuals with good lifestyle factors, such as not over-consuming alcohol, eating a healthy diet, doing exercise, not smoking and being of normal weight, are 80% less likely to develop Diabetes Type 2 over an 11-year period, compared to those with bad lifestyle factors, researchers from the National Heart, Lung, and Blood Institute, Bethesda, and National Cancer Institute, Rockville, Maryland, and AARP, Washington, DC. | 06 Sept 2011 |
| New Tactic For Controlling Blood Sugar In Diabetes Contradicts Current View Of The Disease Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice. | 06 Sept 2011 |
| New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. | 06 Sept 2011 |
| Inflammation In Diabetes May Be Part Of The Solution, Not The Problem Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice. | 06 Sept 2011 |
| DMP For Diabetes Type 1: Guidelines Indicate Some Need For Revision On 22 August 2011, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with diabetes mellitus type 1. | 06 Sept 2011 |
| Endocrinology News | |
| Diabetes Risk 80% Lower For Those With Multiple Good Lifestyle Factors, Compared To Those With Worst Individuals with good lifestyle factors, such as not over-consuming alcohol, eating a healthy diet, doing exercise, not smoking and being of normal weight, are 80% less likely to develop Diabetes Type 2 over an 11-year period, compared to those with bad lifestyle factors, researchers from the National Heart, Lung, and Blood Institute, Bethesda, and National Cancer Institute, Rockville, Maryland, and AARP, Washington, DC. | 06 Sept 2011 |
| Epilepsy News | |
| Non-Epileptic Seizures May Be Misdiagnosed Longer In Veterans Psychogenic non-epileptic seizures may go undiagnosed for much longer in veterans compared to civilians, according to a new study published in the September 6, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. | 06 Sept 2011 |
| Erectile Dysfunction / Premature Ejaculation News | |
| VIVUS Announces FDA Acceptance Of Avanafil New Drug Application For Treatment Of Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its investigational drug candidate, avanafil, for the treatment of erectile dysfunction (ED). | 06 Sept 2011 |
| Fertility News | |
| Who's Your Daddy? Is It Time For Sperm Donor Regulation? There is a debate that has resurfaced this week over whether or not sperm donorship should be government regulated. In fact a recent report states that a single sperm donor may have fathered at least 150 children for example. | 06 Sept 2011 |
| Flu / Cold / SARS News | |
| FAO Warnings Follow Rise In Replikins Count For Both H5N1 And Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a matter of global concern (1, 2). Bioradar UK Ltd announced (3) first, that the Replikin Counts of the two virus strains have risen simultaneously, not seen previously. | 06 Sept 2011 |
| Pa. Department Of Health, CDC Advise Public Of Novel Influenza Case The Pennsylvania Department of Health is advising the public of an investigation into a human case of novel influenza A virus in Pennsylvania and is urging the public to take everyday precautions to prevent the spread of respiratory viruses. | 06 Sept 2011 |
| GastroIntestinal / Gastroenterology News | |
| Scientists Grow Human Colon Stem Cells In A Lab-Plate For the first time researchers of the Colorectal Cancer Lab at the Institute for Research and Biomedicine (IRB Barcelona) identified and managed to grow human colon stem cells in a lab-plate. | 06 Sept 2011 |
| Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis Young Canadians living with the debilitating inflammatory bowel disease ulcerative colitis (UC) will now have access to a new treatment option with Health Canada's approval of REMICADE® (infliximab) for use in pediatric patients (age six to 17 years). | 06 Sept 2011 |
| Stomach Bacterium Damages Human DNA The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world. Molecular biologists from the University of Zurich have now identified a mechanism of Helicobacter pylori that damages the DNA of cells in the gastric mucosa and sets them up for malignant transformation. | 06 Sept 2011 |
| Genetics News | |
| Researchers Find Missing Genes May Separate Couch Potato From Active Cousin You may think your lack of resolve to get off the couch to exercise is because you're lazy, but McMaster University researchers have discovered it may be you are missing key genes.The researchers made their unexpected finding while working with healthy, specially-bred mice, some of which had two genes in muscle essential for exercise removed. | 06 Sept 2011 |
| Gene Mutation Shown To Cause Leukaemia And Lymphoedema Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia. The identification of the gene responsible for causing this rare combination of medical conditions, known as Emberger syndrome, could allow earlier identification and treatment of those at risk. | 06 Sept 2011 |
| New Strategy For Treating Cancer Using a strategy based on treating cancer cells that carry a specific genetic signature hyper-expression of the protein Myc with therapy that affects the stability of the cell's DNA, more effective results can be achieved. | 06 Sept 2011 |
| Stomach Bacterium Damages Human DNA The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world. Molecular biologists from the University of Zurich have now identified a mechanism of Helicobacter pylori that damages the DNA of cells in the gastric mucosa and sets them up for malignant transformation. | 06 Sept 2011 |
| Crowd-Sourcing The E. Coli O104:H4 Outbreak Ten variants of the deadly Escherichia coli strain that hit Germany in May 2011 have been sequenced across the world. The unprecedented level of collaboration across the scientific community should give insight into how the outbreak arose, says a scientist at the Society for General Microbiology's Autumn Conference 2011. | 06 Sept 2011 |
| NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. | 06 Sept 2011 |
| An 'Unconventional' Path To Correcting Cystic Fibrosis Researchers have identified an unconventional path that may correct the defect underlying cystic fibrosis, according to a report in the September 2nd issue of the journal Cell, a Cell Press publication. | 06 Sept 2011 |
| Heart Disease News | |
| Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or 'Off-The-Shelf' Stem Cell Treatment For Heart Attacks Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. | 06 Sept 2011 |
| AHA Gives Loyola $195,000, Bringing Lifetime Total To $10.1 Million The American Heart Association has awarded the Cardiovascular Institute of Loyola University Chicago Stritch School of Medicine $194,772 for cardiac research in 2011, bringing the lifetime total awarded to Loyola to $10. | 06 Sept 2011 |
| HIV / AIDS News | |
| New HIV Vaccine Approach Targets Desirable Immune Cells Researchers at Duke University Medical Center, Beth Israel Deaconess Medical Center and Harvard Medical School have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein. | 06 Sept 2011 |
| Immune System / Vaccines News | |
| In Mouse Model, Potential Vaccine Readies Immune System To Kill Tuberculosis A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response. | 06 Sept 2011 |
| FAO Warnings Follow Rise In Replikins Count For Both H5N1 And Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a matter of global concern (1, 2). Bioradar UK Ltd announced (3) first, that the Replikin Counts of the two virus strains have risen simultaneously, not seen previously. | 06 Sept 2011 |
| Inflammation In Diabetes May Be Part Of The Solution, Not The Problem Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice. | 06 Sept 2011 |
| NIH Scientists Repurpose FDA-Approved Drug To Target Specific Defect Causing WHIM Syndrome A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome. | 06 Sept 2011 |
| Tricking The Body To Heal Itself With Low-Dose Naltrexone (LDN) Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) to treat cancer and autoimmune diseases, exerts a profound inhibitory effect on cell proliferation. | 06 Sept 2011 |
| New HIV Vaccine Approach Targets Desirable Immune Cells Researchers at Duke University Medical Center, Beth Israel Deaconess Medical Center and Harvard Medical School have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein. | 06 Sept 2011 |
| Infectious Diseases / Bacteria / Viruses News | |
| Neurological Complications Relating To E. Coli Considerably Improved When Flushing Out Antibody An article published in The Lancet reports that people's symptoms with neurological complications after Escherichia coli infection drastically improved when the body's IgG antibodies were flushed out. | 06 Sept 2011 |
| Blood Supply Threatened By Tickborne Parasite Babesia, Screening Of Blood Donors Required, Says CDC US blood supplies are becoming increasingly infected with Babesia, a tickborne parasite of red blood cells. The infection is transmitted through blood transfusions. Since 1979, when transfusion-associated babesiosis was first reported, the number of reported cases has been progressively increasing, the CDC (Centers for Disease Control and Prevention) announced in Annals of Internal Medicine after carrying out a collaborative study of the last thirty years. | 06 Sept 2011 |
| New Drugs Hope For Dangerous Yeast Infections Researchers are a step closer towards creating a new class of medicines and vaccines to combat drug-resistant and deadly strains of fungal infections, following a new study published today in Proceedings of the National Academy of Sciences. | 06 Sept 2011 |
| Stomach Bacterium Damages Human DNA The stomach bacterium Helicobacter pylori is one of the biggest risk factors for the development of gastric cancer, the third most common cause of cancer-related deaths in the world. Molecular biologists from the University of Zurich have now identified a mechanism of Helicobacter pylori that damages the DNA of cells in the gastric mucosa and sets them up for malignant transformation. | 06 Sept 2011 |
| Crowd-Sourcing The E. Coli O104:H4 Outbreak Ten variants of the deadly Escherichia coli strain that hit Germany in May 2011 have been sequenced across the world. The unprecedented level of collaboration across the scientific community should give insight into how the outbreak arose, says a scientist at the Society for General Microbiology's Autumn Conference 2011. | 06 Sept 2011 |
| New Cancer Killer - A Harmless Soil-Dwelling Bacteria A bacterial strain that specifically targets tumours could soon be used as a vehicle to deliver drugs in frontline cancer therapy. The strain is expected to be tested in cancer patients in 2013 says a scientist at the Society for General Microbiology's Autumn Conference at the University of York. | 06 Sept 2011 |
| IT / Internet / E-mail News | |
| Technology-Enhanced Simulations For Training Of Health Care Professionals Improves Skills And Patient Results The use of Technology Simulations, such as computer-based virtual reality models, high-fidelity and static mannequins, plastic models, live animals, inert animal products, and human cadavers is shown to assist health care professionals in improving their knowledge and skill, as well as increasing the patients' results. | 06 Sept 2011 |
| Made From A Single Molecule: The World's Smallest Electric Motor Chemists at Tufts University's School of Arts and Sciences have developed the world's first single molecule electric motor, a development that may potentially create a new class of devices that could be used in applications ranging from medicine to engineering. | 06 Sept 2011 |
| Medical Students And Simulation Training In Obstetric Clerkship Medical students who practiced on a patient simulator before assisting in real-life vaginal deliveries scored significantly higher on their final examinations than did students receiving a lecture only at the start of an obstetric clerkship. | 06 Sept 2011 |
| Lung Cancer News | |
| Roche's Tarceva Receives European Approval For First-line Use In A Genetically Distinct Type Of Lung Cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Tarceva® (erlotinib) for use in patients with a genetically distinct type of non-small cell lung cancer (NSCLC) in Europe. | 06 Sept 2011 |
| New Drug Approved For Treatment Of Non Small Cell Lung Cancer In Specific Patient Population Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival. | 06 Sept 2011 |
| Lymphoma / Leukemia / Myeloma News | |
| Gene Mutation Shown To Cause Leukaemia And Lymphoedema Researchers have discovered a gene that when mutated can cause lymphoedema (swollen limbs due to a failure of the lymph system), immune abnormalities, deafness and leukaemia. The identification of the gene responsible for causing this rare combination of medical conditions, known as Emberger syndrome, could allow earlier identification and treatment of those at risk. | 06 Sept 2011 |
| Mechanism Discovered That Can Help Design Future Therapies For Leukemia An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations. | 06 Sept 2011 |
| Medical Devices / Diagnostics News | |
| Made From A Single Molecule: The World's Smallest Electric Motor Chemists at Tufts University's School of Arts and Sciences have developed the world's first single molecule electric motor, a development that may potentially create a new class of devices that could be used in applications ranging from medicine to engineering. | 06 Sept 2011 |
| Zero-Gravity Experiments To Help Future NASA Astronauts Researchers from Louisiana Tech University will be floating high above the Gulf of Mexico this month to conduct zero-gravity testing of an experimental DNA analysis instrument developed at Tech that could benefit future NASA astronauts. | 06 Sept 2011 |
| Profiler At The Cellular Level Researchers led by ETH professor Yaakov Benenson and MIT professor Ron Weiss have successfully incorporated a diagnostic biological "computer" network in human cells. This network recognizes certain cancer cells using logic combinations of five cancer-specific molecular factors, triggering cancer cells destruction. | 06 Sept 2011 |
| Medical Practice Management News | |
| Burnout And Low Quality Of Life Reported In Large Proportion Of Internal Medicine Residents According to an investigation in the September 7 issue of JAMA, a medical education theme issue in a recent academic year, suboptimal quality-of-life, dissatisfaction with work-life balance, and burnout symptoms of emotional exhaustion which were linked with higher levels of educational debt were frequently reported in the study that consisted of almost three-fourths of all internal medicine residents in the U. | 06 Sept 2011 |
| Medical Students / Training News | |
| Factors That Influence Medical Students' Likelihood Of Becoming Board Certified According to a report in the September 7 issue of JAMA, a medical education theme issue, the likelihood of a medical school graduate becoming board certified is linked with certain factors, such as race/ethnicity, age at graduation and level of debt. | 06 Sept 2011 |
| Technology-Enhanced Simulations For Training Of Health Care Professionals Improves Skills And Patient Results The use of Technology Simulations, such as computer-based virtual reality models, high-fidelity and static mannequins, plastic models, live animals, inert animal products, and human cadavers is shown to assist health care professionals in improving their knowledge and skill, as well as increasing the patients' results. | 06 Sept 2011 |
| Education For Medical Students Relating To The Health Of Gay, Lesbian, Bisexual And Trans-Gender Patients Is Only Five Hours On Average According to an investigation in the September 7 issue of JAMA, a medical education theme issue, approximately 5 hours is the median (midpoint) amount of time in the medical school curriculum assigned to topics associated to health care needs of lesbian, gay, bisexual and transgender patients. | 06 Sept 2011 |
| Investigation Reviews Occurrence Of Unconscious Race And Social Preference In Medical Students According to a report in the September 7 issue of JAMA, a medical education theme issue, in one medical school, most first-year students' scores who were surveyed in regards to race and social preference, were coherent with an unconscious preference towards white people and upper social class, even though when a variety of different clinical scenarios were presented to the student's, these biases were not linked in their decision making or clinical assessments. | 06 Sept 2011 |
| Medical Students And Simulation Training In Obstetric Clerkship Medical students who practiced on a patient simulator before assisting in real-life vaginal deliveries scored significantly higher on their final examinations than did students receiving a lecture only at the start of an obstetric clerkship. | 06 Sept 2011 |
| Men's health News | |
| Study Suggests Sexual Orientation Unconsciously Affects Our Impressions Of Others Studies by psychologists at the University of Toronto reveal that when it comes to white men, being straight may make you more likable but in the case of black men, gays have a likability edge. | 06 Sept 2011 |
| Mental Health News | |
| CDC Says Mental Illness Plagues US Like Never Before Mental illness is a real issue. Now the Centers for Disease Control and Prevention have taken a harder look at the issue and have uncovered some alarming realities. About half of Americans will experience some form of mental health problem at some point in their life, and more must be done to help them. | 06 Sept 2011 |
| Neurology / Neuroscience News | |
| Neurological Complications Relating To E. Coli Considerably Improved When Flushing Out Antibody An article published in The Lancet reports that people's symptoms with neurological complications after Escherichia coli infection drastically improved when the body's IgG antibodies were flushed out. | 06 Sept 2011 |
| Valdoxan More Effective On Patients With Major Depressive Disorder Than Common Antidepressants The European College of Neuropsychopharmacology Congress (ECNP) highlighted new data regarding the high efficiency of Valdoxan® (agomelatine) in comparison with other commonly prescribed antidepressants showing that the drug is stronger and therefore significantly more beneficial for depressed patients with severe anxiety symptoms. | 06 Sept 2011 |
| Non-Epileptic Seizures May Be Misdiagnosed Longer In Veterans Psychogenic non-epileptic seizures may go undiagnosed for much longer in veterans compared to civilians, according to a new study published in the September 6, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. | 06 Sept 2011 |
| Nursing / Midwifery News | |
| Medical Students And Simulation Training In Obstetric Clerkship Medical students who practiced on a patient simulator before assisting in real-life vaginal deliveries scored significantly higher on their final examinations than did students receiving a lecture only at the start of an obstetric clerkship. | 06 Sept 2011 |
| Nutrition / Diet News | |
| McDonald's New Menu Includes Calorie Information, UK The Department of Health announced today that starting this Wednesday, McDonald's will be introducing calorie information to all of its menus in all of its 1,200 UK restaurants, to allow consumers to see calorie information of every article on their menu at a glance. | 06 Sept 2011 |
| Walnuts Reduce Breast Cancer Risk By Half In Animal Studies Mice fed a diet that included daily walnuts had half the risk of developing breast cancer compared to those on a typical diet, researchers from Marshal University School of Medicine reported in the journal Nutrition and Cancer. | 06 Sept 2011 |
| Obesity / Weight Loss / Fitness News | |
| McDonald's New Menu Includes Calorie Information, UK The Department of Health announced today that starting this Wednesday, McDonald's will be introducing calorie information to all of its menus in all of its 1,200 UK restaurants, to allow consumers to see calorie information of every article on their menu at a glance. | 06 Sept 2011 |
| Researchers Find Missing Genes May Separate Couch Potato From Active Cousin You may think your lack of resolve to get off the couch to exercise is because you're lazy, but McMaster University researchers have discovered it may be you are missing key genes.The researchers made their unexpected finding while working with healthy, specially-bred mice, some of which had two genes in muscle essential for exercise removed. | 06 Sept 2011 |
| New Class Of Anti-Diabetic Compound Established By Scripps Research Scientists In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch. | 06 Sept 2011 |
| Inflammation In Diabetes May Be Part Of The Solution, Not The Problem Increased low-grade inflammation in the body resulting from obesity is widely viewed as contributing to type 2 diabetes. Going against this long-held belief, researchers from Children's Hospital Boston report that two proteins activated by inflammation are actually crucial for maintaining good blood sugar levels - and that boosting the activity of these proteins can normalize blood sugar in severely obese and diabetic mice. | 06 Sept 2011 |
| Pediatrics / Children's Health News | |
| Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis Young Canadians living with the debilitating inflammatory bowel disease ulcerative colitis (UC) will now have access to a new treatment option with Health Canada's approval of REMICADE® (infliximab) for use in pediatric patients (age six to 17 years). | 06 Sept 2011 |
| First Irish Study Shows Weight Difference In Twins At Birth Is Key Predictor Of Health Complications The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins. | 06 Sept 2011 |
| Mechanism Discovered That Can Help Design Future Therapies For Leukemia An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations. | 06 Sept 2011 |
| Stability For Children Is The Goal Of Social Workers Aiming To Strengthen Relationships, Marriages Child welfare professionals know that children are safer and healthier when the adults in their lives have healthy relationships, but most social workers are not trained to educate couples about strong relationships and marriages. | 06 Sept 2011 |
| Infants Trained To Concentrate Show Added Benefits Although parents may have a hard time believing it, even infants can be trained to improve their concentration skills. What's more, training babies in this way leads to improvements on other, unrelated tasks. | 06 Sept 2011 |
| Pharma Industry / Biotech Industry News | |
| Roche's Tarceva Receives European Approval For First-line Use In A Genetically Distinct Type Of Lung Cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Tarceva® (erlotinib) for use in patients with a genetically distinct type of non-small cell lung cancer (NSCLC) in Europe. | 06 Sept 2011 |
| Chugai Initiates Clinical Trials For Multiple In-Licensed Compounds Utilizing The Personalized Healthcare Strategy Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President: Osamu Nagayama (hereafter, "Chugai")] announced that it has entered into license agreements with F. Hoffmann-La Roche, Ltd [Head Office: Basel, Switzerland / CEO: Severin Schwan (hereafter, "Roche")] covering humanized anti-Met antibody MetMAb, for non-small cell lung cancer (NSCLC) and humanized anti-interleukin(IL)-13 antibody lebrikizumab for bronchial asthma which are both currently developed by Roche utilizing the Personalized Healthcare (PHC) approach and have also entered phase I clinical studies in the Japanese population. | 06 Sept 2011 |
| VIVUS Announces FDA Acceptance Of Avanafil New Drug Application For Treatment Of Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its investigational drug candidate, avanafil, for the treatment of erectile dysfunction (ED). | 06 Sept 2011 |
| Pharmacy / Pharmacist News | |
| Study Identifies 'respectable Addicts' Experiencing Range Of Problems With Over-the-counter Medicines A report of a study investigating over the counter medicine (OTC) abuse published by the Pharmacy Practice Research Trust provides evidence that there is a group of individuals experiencing a range of problems often with codeine-based medicines purchased from pharmacies, and for whom help and support varied. | 06 Sept 2011 |
| Pregnancy / Obstetrics News | |
| Who's Your Daddy? Is It Time For Sperm Donor Regulation? There is a debate that has resurfaced this week over whether or not sperm donorship should be government regulated. In fact a recent report states that a single sperm donor may have fathered at least 150 children for example. | 06 Sept 2011 |
| First Irish Study Shows Weight Difference In Twins At Birth Is Key Predictor Of Health Complications The first results of a major all-Ireland study of twin pregnancies, led by Perinatal Ireland and the Royal College of Surgeons in Ireland (RCSI) and funded by the Health Research Board, has shown that a major difference in the birth weights among a pair of twin babies results in an increased risk of health complications for both twins. | 06 Sept 2011 |
| Preventive Medicine News | |
| Pa. Department Of Health, CDC Advise Public Of Novel Influenza Case The Pennsylvania Department of Health is advising the public of an investigation into a human case of novel influenza A virus in Pennsylvania and is urging the public to take everyday precautions to prevent the spread of respiratory viruses. | 06 Sept 2011 |
| Psychology / Psychiatry News | |
| Study Suggests Sexual Orientation Unconsciously Affects Our Impressions Of Others Studies by psychologists at the University of Toronto reveal that when it comes to white men, being straight may make you more likable but in the case of black men, gays have a likability edge. | 06 Sept 2011 |
| Stability For Children Is The Goal Of Social Workers Aiming To Strengthen Relationships, Marriages Child welfare professionals know that children are safer and healthier when the adults in their lives have healthy relationships, but most social workers are not trained to educate couples about strong relationships and marriages. | 06 Sept 2011 |
| Public Health News | |
| Pa. Department Of Health, CDC Advise Public Of Novel Influenza Case The Pennsylvania Department of Health is advising the public of an investigation into a human case of novel influenza A virus in Pennsylvania and is urging the public to take everyday precautions to prevent the spread of respiratory viruses. | 06 Sept 2011 |
| BBC's Holby City Criticized By Trauma Experts For 'Peddling Dangerous Drugs' Trauma experts have criticized the BBC over a recent episode of Holby City that effectively advertised and promoted a drug that has no proven record of saving lives.According to Dr Ian Roberts, Head of the World Health Organisation Collaborating Centre on Injury Control at the London School of Hygiene & Tropical Medicine, the recent episode ("Big Lies, Small Lies") seriously misrepresents the scientific evidence. | 06 Sept 2011 |
| Stability For Children Is The Goal Of Social Workers Aiming To Strengthen Relationships, Marriages Child welfare professionals know that children are safer and healthier when the adults in their lives have healthy relationships, but most social workers are not trained to educate couples about strong relationships and marriages. | 06 Sept 2011 |
| Zero-Gravity Experiments To Help Future NASA Astronauts Researchers from Louisiana Tech University will be floating high above the Gulf of Mexico this month to conduct zero-gravity testing of an experimental DNA analysis instrument developed at Tech that could benefit future NASA astronauts. | 06 Sept 2011 |
| Regulatory Affairs / Drug Approvals News | |
| Young Patients To Benefit From Health Canada Approval Of Remicade®* For Treatment Of Pediatric Ulcerative Colitis Young Canadians living with the debilitating inflammatory bowel disease ulcerative colitis (UC) will now have access to a new treatment option with Health Canada's approval of REMICADE® (infliximab) for use in pediatric patients (age six to 17 years). | 06 Sept 2011 |
| Roche's Tarceva Receives European Approval For First-line Use In A Genetically Distinct Type Of Lung Cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Tarceva® (erlotinib) for use in patients with a genetically distinct type of non-small cell lung cancer (NSCLC) in Europe. | 06 Sept 2011 |
| New Drug Approved For Treatment Of Non Small Cell Lung Cancer In Specific Patient Population Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival. | 06 Sept 2011 |
| VIVUS Announces FDA Acceptance Of Avanafil New Drug Application For Treatment Of Erectile Dysfunction VIVUS, Inc. (NASDAQ: VVUS) announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application (NDA) for its investigational drug candidate, avanafil, for the treatment of erectile dysfunction (ED). | 06 Sept 2011 |
| Respiratory / Asthma News | |
| Chugai Initiates Clinical Trials For Multiple In-Licensed Compounds Utilizing The Personalized Healthcare Strategy Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President: Osamu Nagayama (hereafter, "Chugai")] announced that it has entered into license agreements with F. Hoffmann-La Roche, Ltd [Head Office: Basel, Switzerland / CEO: Severin Schwan (hereafter, "Roche")] covering humanized anti-Met antibody MetMAb, for non-small cell lung cancer (NSCLC) and humanized anti-interleukin(IL)-13 antibody lebrikizumab for bronchial asthma which are both currently developed by Roche utilizing the Personalized Healthcare (PHC) approach and have also entered phase I clinical studies in the Japanese population. | 06 Sept 2011 |
| Smoking / Quit Smoking News | |
| Fewer Heavy Smokers, More Light Smokers In USA, New Study Reveals 19.3% of American adults smoked in 2010, compared to 20.9% in 2005. There are 45.3 million adult smokers in the USA. Those who smoke every day appear to be consuming fewer cigarettes than they used to, a Vital Signs report issued by the CDC (Centers for Disease Control and Prevention) informs. | 06 Sept 2011 |
| Stem Cell Research News | |
| Scientists Grow Human Colon Stem Cells In A Lab-Plate For the first time researchers of the Colorectal Cancer Lab at the Institute for Research and Biomedicine (IRB Barcelona) identified and managed to grow human colon stem cells in a lab-plate. | 06 Sept 2011 |
| Mesoblast Receives Clearance To Begin First European Trial Of Allogeneic Or 'Off-The-Shelf' Stem Cell Treatment For Heart Attacks Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor(TM) in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. | 06 Sept 2011 |
| Key Protein Reveals Secret Of Stem Cell Pluripotency A protein that helps maintain mouse stem cell pluripotency has been identified by researchers at the RIKEN Omics Science Center. The finding, published in the August issue of Stem Cells (first published online July 26, 2011), points the way to advances in regenerative medicine and more effective culturing techniques for human pluripotent stem cells. | 06 Sept 2011 |
| Human Intestinal Stem Cell 'Breakthrough' For Regenerative Medicine Announced By Scientists Human colon stem cells have been identified and grown in a lab-plate for the first time. This achievement, made by researchers of the Colorectal Cancer Lab at the Institute for Research in Biomedicine (IRB Barcelona) and published in /i>Nature Medicine, is a crucial advance towards regenerative medicine. | 06 Sept 2011 |
| Swine Flu News | |
| FAO Warnings Follow Rise In Replikins Count For Both H5N1 And Swine Flu (H1N1); Replikins Synthetic TransFlu™ Vaccine Tested The possible combination of influenza strains H1N1 (high infectivity) and H5N1 (high lethality) is a matter of global concern (1, 2). Bioradar UK Ltd announced (3) first, that the Replikin Counts of the two virus strains have risen simultaneously, not seen previously. | 06 Sept 2011 |
| Tuberculosis News | |
| In Mouse Model, Potential Vaccine Readies Immune System To Kill Tuberculosis A potential vaccine against tuberculosis has been found to completely eliminate tuberculosis bacteria from infected tissues in some mice. The vaccine was created with a strain of bacteria that, due to the absence of a few genes, are unable to avoid its host's first-line immune response. | 06 Sept 2011 |
| Veterans / Ex-Servicemen News | |
| Non-Epileptic Seizures May Be Misdiagnosed Longer In Veterans Psychogenic non-epileptic seizures may go undiagnosed for much longer in veterans compared to civilians, according to a new study published in the September 6, 2011, print issue of Neurology®, the medical journal of the American Academy of Neurology. | 06 Sept 2011 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar